<DOC>
	<DOCNO>NCT00225589</DOCNO>
	<brief_summary>The purpose trial see rosuvastatin effective decreasing thickness wall arteries neck people already evidence thicken wall .</brief_summary>
	<brief_title>A Study Measuring Effects Intima Media Thickness : An Evaluation Rosuvastatin 40 mg ( METEOR )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Maximum IMT &gt; 1.2 mm 3.5 mm location carotid ultrasound study conduct Visit 2 ( Week 4 ) Visit 3 ( Week 2 ) Subjects age risk factor : Fasting LDLC Visit 1 ( Week 6 ) &gt; 120 mg/dL ( 3.1mmol/L ) &lt; 190 mg/dL ( 4.9 mmol/L ) Subjects 2 risk factor 10year coronary heart disease ( CHD ) risk &lt; 10 % : Fasting LDLC Visit 1 ( Week 6 ) &gt; 120 mg/dL ( 3.1 mmol/L ) &lt; 160 mg/dL ( 4.1 mmol/L ) Use pharmacologic lipidlowering medication ( eg , HMGCoA reductase inhibitor , fibrate derivative , bile acid binding resin , niacin analogue dose &gt; 400 mg ) within 12 month prior Visit 1 ( Week 6 ) . Clinical evidence coronary artery disease atherosclerotic disease angina , MI , TIA , symptomatic carotid artery disease , CVA , CABG , PTCA , peripheral arterial disease , AAA .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Hypercholesteremia</keyword>
</DOC>